Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice

por Masahiro Matsui, Shinya Fukunishi, Takashi Nakano, Takaaki Ueno, Kazuhide Higuchi, Akira Asai
Publicado 2021

Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell lines

por Keisuke Taniguchi, Hiroaki Konishi, Akiko Yoshinaga, Momomi Tsugane, Hiroyuki Takahashi, Fukiko Nishisaka, Yoshiyuki Shishido, Akira Asai
Publicado 2021

Hepatectomy and liver regeneration in the results of treatment of colorectal liver metastasis

por Yoshihiro Inoue, Masatsugu Ishii, Keisuke Yokohama, Hideko Ohama, Yusuke Tsuchimoto, Tetsuji Terazawa, Akira Asai, Shinya Fukunishi, Kazuhide Higuchi, Kazuhisa Uchiyama
Publicado 2020

Diabetes mellitus does not influence results of hepatectomy in hepatocellular carcinoma: case control study

por Yoshihiro Inoue, Yusuke Suzuki, Keisuke Yokohama, Hideko Ohama, Yusuke Tsuchimoto, Akira Asai, Shinya Fukunishi, Fumiharu Kimura, Kazuhide Higuchi, Kazuhisa Uchiyama
Publicado 2021